Clinical Trial Update: GFRα4 CAR T Cells in MTC Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GFRα4 CAR T cells for metastatic medullary thyroid carcinoma; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• GFRα4 CAR T Cells (GFRα4-targeted CAR T cell therapy)

Snippet

Sponsor: University of Pennsylvania | Conditions: Metastatic Medullary Thyroid Cancer, Recurrent Thyroid Gland Medullary Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING